Vanguard Capital Management
APYX icon

Vanguard Capital Management’s Apyx Medical APYX Stock Holding History

Vanguard Capital Management’s Portfolio APYX Stock Details APYX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.89M Sell
1,534,847
-20,425
-1% -$81K ﹤0.01% 2995
2026
Q1 		$5.74M Buy
+1,555,272
New +$5.81M ﹤0.01% 3002

Other funds holding APYX

RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3B AUM 119.43% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SBCM
Silverberg Bernstein Capital Management Armonk, New York $261M AUM 89.93% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
HKAM
Horizon Kinetics Asset Management New York $8.82B AUM 23.05% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $214M AUM 47.29% 1-Year Est. Return

Vanguard Capital Management's APYX Position: Q2 2026 in Review

Vanguard Capital Management reduced its Apyx Medical (APYX) stake by 1.3% in Q2 2026, selling an estimated $81K and leaving 1,534,847 shares worth $6.89M. The position accounts for ﹤0.01% of the portfolio, ranked #2995.

Vanguard Capital Management first reported a position in APYX in Q1 2026 and has held it in 2 quarters since. 65 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Vanguard Capital Management held 1,534,847 shares of Apyx Medical worth $6.89M as of Q2 2026.
  • Vanguard Capital Management sold 20,425 Apyx Medical shares in Q2 2026, an estimated $81K.
  • Apyx Medical made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2995 holding.
  • Vanguard Capital Management first reported a position in Apyx Medical in Q1 2026 and has held it in 2 quarters since.
  • 65 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.